Literature DB >> 20081550

Proptosis in dysthyroid ophthalmopathy: a case series of 10,931 Japanese cases.

Ai Kozaki1, Rishu Inoue, Noriko Komoto, Toshine Maeda, Yoichi Inoue, Toshu Inoue, Masahiko Ayaki.   

Abstract

PURPOSE: This observational case series investigated the occurrence and distribution of proptosis in Japanese patients with dysthyroid ophthalmopathy (DO). The relationship among lid retraction, lid swelling, and enlargement of extraocular muscles was also analyzed.
METHODS: From 1993 to 2002, 10 931 patients (2240 men and 8691 women, average age; 39.9 ± 14.0 years) with abnormal thyroid function were examined for proptosis. Proptosis was measured using a Hertel exophthalmometer, and lid swelling and retraction were classified. Orbital magnetic resonance imaging or computed tomography was used to quantify enlargement of the extraocular muscles.
RESULTS: Clinically significant proptosis (≥15 mm) was present in 74.2% patients and was classified as mild (15-17 mm, 39.1%), moderate (18-20 mm, 25.9%), or severe (>20 mm, 9.2%). The average exophthalmometer reading was 17.2 ± 3.2 mm, with proptosis less pronounced with age (p < 0.001) and more pronounced in men than women (18.2 ± 3.4 mm vs. 17.0 ± 3.1 mm; p < 0.001). Lid retraction was present in 57.7% of patients, lid swelling in 46.9%, and muscle enlargement in 40.8% of patients. Multiple regression analysis revealed proptosis was strongly correlated with a young age and the male gender, followed by extraocular muscle enlargement and lid retraction and swelling (p < 0.001).
CONCLUSIONS: This study assessed the measurable features of proptosis in Japanese patients with DO and contributes to the understanding by correlating symptoms and signs of DO.

Entities:  

Mesh:

Year:  2010        PMID: 20081550     DOI: 10.1097/OPX.0b013e3181ce5702

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  7 in total

Review 1.  Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature.

Authors:  Ozan Cem Guler; Cem Onal; Gungor Arslan
Journal:  Wien Klin Wochenschr       Date:  2015-10-14       Impact factor: 1.704

2.  Clinical Characteristics of Idiopathic Orbital Inflammation Syndrome in Relation to Intraocular Pressure.

Authors:  Mitsuya Otsuka; Tatsuya Yunoki; Hironori Ozaki; Atsushi Hayashi
Journal:  Clin Ophthalmol       Date:  2022-05-11

3.  Age differences in clinical manifestation and prognosis of thyroid eye disease.

Authors:  Guy J Ben Simon; Gabriel Katz; Ofira Zloto; Hana Leiba; Beatrix Hadas; Ruth Huna-Baron
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-07       Impact factor: 3.117

4.  Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.

Authors:  Qian Li; Huijing Ye; Yungang Ding; Guo Chen; Zhichang Liu; Jianan Xu; Rongxin Chen; Huasheng Yang
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

5.  Clinical efficacy of transcutaneous triamcinolone acetonide injection for upper eyelid retraction and swelling in patients with thyroid eye disease.

Authors:  Ai Kozaki; Hiroshi Nakamura; Toshu Inoue
Journal:  Int Med Case Rep J       Date:  2018-11-09

Review 6.  Epidemiology, Natural History, Risk Factors, and Prevention of Graves' Orbitopathy.

Authors:  Luigi Bartalena; Eliana Piantanida; Daniela Gallo; Adriana Lai; Maria Laura Tanda
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-30       Impact factor: 5.555

7.  Automated detection of enlarged extraocular muscle in Graves' ophthalmopathy with computed tomography and deep neural network.

Authors:  Kaori Hanai; Hitoshi Tabuchi; Daisuke Nagasato; Mao Tanabe; Hiroki Masumoto; Sakurako Miya; Natsuno Nishio; Hirohiko Nakamura; Masato Hashimoto
Journal:  Sci Rep       Date:  2022-09-26       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.